|
시장보고서
상품코드
2077668
조직 플라스미노겐 활성제(tPA) 시장 : 약제 종류별, 용도별, 지역별Tissue Plasminogen Activator Market, By Drug Type, By Application, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
조직 플라스미노겐 활성제(tPA) 시장은 2026년에 30억 달러 규모에 달할 것으로 추정되며, 2033년까지 43억 4,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 5.4%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 30억 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 5.40% | 2033년 시장 규모 예측: | 43억 4,000만 달러 |
조직 플라스미노겐 활성제(tPA)는 혈전용해에 관여하는 효소입니다. 이것은 내피 세포에 존재하는 세린 프로테아제입니다. 세린 프로테아제의 작용에 의해 플라스미노겐이 플라스민으로 전환되는 과정이 촉매됩니다. 세린 프로테아제는 혈전용해에 중요한 역할을 하는 주요 효소입니다.
시장 역학
예측 기간 동안 허혈성 뇌졸중 유병률의 증가가 전 세계 조직 플라스미노겐 활성제 시장의 성장을 견인할 것으로 예상됩니다. 예를 들어, 2019년에 발표된 건강지표평가연구소(IHME)의 보고서에 따르면, 전 세계적으로 허혈성 뇌졸중 환자 수는 약 6,350만 명(95% 신뢰구간 5,780만-6,900만)에 달했습니다. 2019년, 전 세계적으로 허혈성 뇌졸중으로 인한 사망자 수는 329만 명(297-354)에 달했으며, 신규 발병자 수는 남성이 345만 명(296-403), 여성이 419만 명(361-491)이었습니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 조직 플라스미노겐 활성제(tPA) 시장의 주요 기업 개요을 작성하고 있습니다. 구체적으로는 기업 개요, 재무 실적, 제품 포트폴리오, 시장 내 입지, 유통 전략, 주요 발전 사항, 전략 및 향후 계획입니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 본 '세계 조직 플라스미노겐 활성제(tPA) 시장 보고서'는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 조직 플라스미노겐 활성제 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 조직 플라스미노겐 활성제(tPA) 시장 : 약물 유형별, 2021-2033년
제5장 세계의 조직 플라스미노겐 활성제(tPA) 시장 : 용도별, 2021-2033년
제6장 세계의 조직 플라스미노겐 활성제(tPA) 시장 : 지역별, 2021-2033년
제7장 경쟁 구도
제8장 섹션
KSM 26.07.08Tissue Plasminogen Activator Market is estimated to be valued at USD 3.00 Bn in 2026 and is expected to reach USD 4.34 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.00 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.40% | 2033 Value Projection: | USD 4.34 Bn |
Tissue plasminogen activator (tPA) is an enzyme associated with the disintegration of blood clots. It is a serine protease present in endothelial cells. With the help of serine protease, the conversion of plasminogen to plasmin is catalyzed. Serine protease is a major enzyme for clot disintegration.
Market Dynamics
The increasing prevalence of ischemic strokes is expected to drive growth of the global tissue plasminogen activator market over the forecast period. For instance, Institute for Health Metrics and Evaluation report published in 2019, ischemia heart stroke accounted for around 63.5 million (95% UI 57*8-69*0) people globally. Ischemic stroke was responsible for 3.29 million (2*97-3*54) deaths in 2019 globally, with 3.45 million (2*96-4*03) incident cases in males and 4.19 million (3*61-4*91) in females.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global tissue plasminogen activator market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include F. Hoffmann-La Roche AG, Boehringer Ingelheim GmbH, CHIESI Farmaceutici S.p.A., Gennova Biopharmaceuticals Ltd, Abbott Laboratories, and Reliance Life Sciences
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global tissue plasminogen activator market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue plasminogen activator market
Detailed Segmentation:
- Global Tissue Plasminogen Activator Market, By Drug Type (Revenue, USD Bn, 2021 - 2033)
- Alteplase
- Reteplase
- Tenecteplase
- Global Tissue Plasminogen Activator Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Ischemic Stroke
- Myocardial Infarction
- Pulmonary Embolism
- Thrombolysis
- Others
- Global Tissue Plasminogen Activator Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- By Drug Type
- Alteplase
- Reteplase
- Tenecteplase
- By Application
- Ischemic Stroke
- Myocardial Infarction
- Pulmonary Embolism
- Thrombolysis
- Others
- By Country
- U.S.
- Canada
- By Drug Type
- Latin America
- By Drug Type
- Alteplase
- Reteplase
- Tenecteplase
- By Application
- Ischemic Stroke
- Myocardial Infarction
- Pulmonary Embolism
- Thrombolysis
- Others
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Drug Type
- Europe
- By Drug Type
- Alteplase
- Reteplase
- Tenecteplase
- By Application
- Ischemic Stroke
- Myocardial Infarction
- Pulmonary Embolism
- Thrombolysis
- Others
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Drug Type
- Asia Pacific
- By Drug Type
- Alteplase
- Reteplase
- Tenecteplase
- By Application
- Ischemic Stroke
- Myocardial Infarction
- Pulmonary Embolism
- Thrombolysis
- Others
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Drug Type
- Middle East
- By Drug Type
- Alteplase
- Reteplase
- Tenecteplase
- By Application
- Ischemic Stroke
- Myocardial Infarction
- Pulmonary Embolism
- Thrombolysis
- Others
- By Country
- GCC
- Israel
- Rest of Middle East
- By Drug Type
- Africa
- By Drug Type
- Alteplase
- Reteplase
- Tenecteplase
- By Application
- Ischemic Stroke
- Myocardial Infarction
- Pulmonary Embolism
- Thrombolysis
- Others
- By Country/Region
- South Africa
- Central Africa
- North Africa
- By Drug Type
- Company Profiles
- F. Hoffmann-La Roche AG *
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Boehringer Ingelheim GmbH
- CHIESI Farmaceutici S.p.A.
- Gennova Biopharmaceuticals Ltd
- Abbott Laboratories
- Reliance Life Sciences
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trend
- Epidemiology
- Key Developments
- Regulatory Scenario
- PEST Analysis
- Pipeline Analysis
- Acquisition and Collaboration Scenario
4. Global Tissue Plasminogen Activator Market, By Drug Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Alteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Reteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
- Tenecteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
5. Global Tissue Plasminogen Activator Market, By Application, 2021-2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Ischemic Stroke
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
- Myocardial Infarction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
- Pulmonary Embolism
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
- Thrombolysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
6. Global Tissue Plasminogen Activator Market, By Region, 2021-2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 -2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- F. Hoffmann-La Roche AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Boehringer Ingelheim GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- CHIESI Farmaceutici S.p.A.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Gennova Biopharmaceuticals Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Reliance Life Sciences
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- F. Hoffmann-La Roche AG
8. Section
- References
- Research Methodology
- About us and Sales Contact
